-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q2 2024.
- Gyre Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $22M, a 9.82% decline year-over-year.
- Gyre Therapeutics, Inc. annual Costs and Expenses for 2023 was $181M, a 94.1% increase from 2022.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)